The 2023 ADA Diabetes Guidelines

Every January, the American Diabetes Association publishes the Standards of Care in Diabetes. The guidelines are a living document and change throughout the year; however, the January update is the seminal changes for the entire document. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss what’s new and great in the guidelines.The GameChangerIn addition to medication recommendations, the guidelines now emphasize the role of Community Health Workers in the management of health-related disparities affecting patients with diabetes. Pharmacotherapy continues to be driven by comorbid conditions and the impact of clinical outcomes, like a cardiovascular or renal disease.Show Segments00:00 - Introductions01:59 - Prevention and Delay of Type 2 Diabetes08:12 - Vaccines and Diabetes10:49 - Continuous Glucose Monitoring Goals17:21 - Glycemic Treatment Updates19:25 - Lipid Goals and Treatment20:39 - The GameChanger: Treatment Recommendations with Comorbid Conditions23:49 - Connecting to Practice: Comorbid Driven Therapy27:31 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCourse Content and Developer, CEimpactManaging Network Facilitator, CPESN Health EquityCEO, SeguridadReferences and ResourcesAmerican Diabetes Association. Standards of Care in Diabetes-2023 Abridged for Primary Care Providers. Redeem your CPE hereCPE (Pharmacist) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the goal for continuous glucose monitoring in diabetes patients2. Describe the lipid goals in patients with diabetes and treatment recommendations3. Describe treatment recommendations for patients with diabetes and chronic kidney disease0.05 CEU/0.5 HrUAN: 0107-0000-23-102-H01-PInitial release date: 03/06/2023Expiration date: 03/06/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram